0001237899-20-000040.txt : 20200903 0001237899-20-000040.hdr.sgml : 20200903 20200903161804 ACCESSION NUMBER: 0001237899-20-000040 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200901 FILED AS OF DATE: 20200903 DATE AS OF CHANGE: 20200903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RYAN ARTHUR F CENTRAL INDEX KEY: 0001187443 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 201159462 MAIL ADDRESS: STREET 1: CITIZENS FINANCIAL GROUP, INC STREET 2: 600 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-09-01 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001187443 RYAN ARTHUR F 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2020-09-01 4 S 0 20 616.74 D 28523 D Common Stock 2020-09-01 4 S 0 20 608.69 D 28503 D Common Stock 2020-09-01 4 S 0 10 605.62 D 28493 D Common Stock 2020-09-01 4 S 0 10 602.33 D 28483 D Common Stock 2020-09-01 4 S 0 20 601.13 D 28463 D Common Stock 2020-09-01 4 S 0 2 600.3 D 28461 D Common Stock 2020-09-01 4 S 0 18 591.5 D 28443 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 20 shares of Company stock on September 1, 2020 at prices ranging from $608.43 to $608.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 1, 2020 at each separate price. Represents volume-weighted average price of sales of 20 shares of Company stock on September 1, 2020 at prices ranging from $601.00 to $601.26. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 1, 2020 at each separate price. /s/**Arthur F. Ryan 2020-09-03